Asciminib Hydrochloride
Metabolites - Asciminib hydrochloride is a targeted tyrosine kinase inhibitor used to treat chronic myeloid leukemia by specifically inhibiting BCR-ABL1 through the STAMP mechanism. Reference standards of Asciminib Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Asciminib Hydrochloride
Catalogue No.:PA 01 4310000
CAS :
2119669-71-3
Molecular Formula : C20H19Cl2F2N5O3
Molecular Weight : 486.3

